GlassScriptPhysician profile
Heather J Morrison
NPI 1801145230
$3,288.08
in general payments reported to CMS, 2019-2025
38 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,249 · 2022: $647 · 2023: $131 · 2024: $160 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $392.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $457.58 | 2021 | |
| Abbvie INC. | $310.63 | 2021-2024 | |
| Biogen, INC. | $307.20 | 2021-2022 | |
| Boston Scientific Corporation | $270.63 | 2022-2024 | Varithena Administration Pack |
| Amgen INC. | $195.39 | 2021-2022 | |
| Ucb, INC. | $191.79 | 2021-2022 | |
| Lilly USA, LLC | $178.10 | 2021-2022 | |
| Acadia Pharmaceuticals INC | $152.23 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $150.84 | 2022 | |
| Saluda Medical Americas, INC. | $111.67 | 2024 | Evoke |
| Csl Behring | $76.81 | 2021-2022 | |
| Lundbeck LLC | $76.78 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $75.85 | 2021-2022 | |
| Averitas Pharma INC. | $67.84 | 2025 | Qutenza |
| Teva Pharmaceuticals USA, INC. | $63.83 | 2021 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $62.77 | 2021 | |
| Alexion Pharmaceuticals, INC. | $54.82 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $43.08 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $42.39 | 2021 | |
| Alnylam Pharmaceuticals INC. | $41.79 | 2021-2022 | |
| Adamas Pharmaceuticals, INC. | $33.62 | 2021 | |
| Kyowa Kirin, INC. | $31.15 | 2021 | |
| Emd Serono, INC. | $27.88 | 2021 | |
| Octapharma USA, INC. | $23.80 | 2021 | |
| Janssen Pharmaceuticals, INC | $23.61 | 2022 | |
| Aquestive Therapeutics, INC. | $22.93 | 2021 | |
| Mallinckrodt Hospital Products INC. | $18.97 | 2021 | |
| Sk Life Science, INC. | $18.94 | 2021 | |
| Tonix Medicines, INC. | $18.17 | 2025 | Tonmya |
| Genzyme Corporation | $17.83 | 2021 | |
| Sunovion Pharmaceuticals INC. | $16.61 | 2021 | |
| Angiodynamics, INC. | $16.33 | 2022 | |
| Mdd US Operations, LLC | $15.86 | 2021 | |
| Allergan, INC. | $15.37 | 2021 | |
| Genentech USA, INC. | $15.10 | 2021 | |
| Si-Bone, INC. | $14.54 | 2025 | |
| Acorda Therapeutics, INC | $12.72 | 2021 | |
| Avion Pharmaceuticals | $12.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.